SIGA Technologies Inc

Financials

Cash from operating activities 56.31 M7.06 M63.08 M-9.81 M-16.86 M 43.47 M Cash from investing activities -17.84 K-24.89 K-1-289.58 K-40.54 K -355.01 K Cash from financing activities -161.76 K-166.19 K-42.89 M-403.48 K-87.82 K -43.55 M Free cash flow 56.29 M7.04 M63.08 M-10.1 M-16.9 M 43.12 M

SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications.

SIGA

Financials

SIGA Technologies Inc

Haberler

Siga Technologies: No News (On BARDA Contract) Not Necessarily Good News (NASDAQ:SIGA)

SIGA Technologies hisse başına 0,60 dolar özel temettü açıkladı

SIGA Technologies’in 4Ç 2025 sonuçları karışık tepki aldı

SIGA Technologies, Inc. (SIGA) Q4 2025 Earnings Call Transcript

Siga Technologies: As Market Waits For MPOXX Purchases, I Remain On The Sidelines (SIGA)

Tesla, Applovin among market cap stock movers on Friday

SIGA Technologies, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SIGA) 2025-11-07

SIGA Technologies, Inc. (SIGA) Q3 2025 Earnings Call Transcript

SIGA Technologies, Inc. (SIGA) Q2 2025 Earnings Call Transcript

3 Healthcare Stocks Paying the Highest Dividends of 2025

Siga Technologies Inc. (SIGA) Stock Falls Amid Market Uptick: What Investors Need to Know

Siga Technologies Inc. (SIGA) Outpaces Stock Market Gains: What You Should Know